Complete buildout of Dallas headquarters
Delivered by the deadline
AI-confirmed · human review in progress Independent AI checks agreed on primary SEC or regulator evidence. Records are now being reviewed by hand, starting with those our customers order.
- Announced
- 1 Feb 2021
- Due
- 30 Jun 2021
- Delivered
- May 2021
- Deadline
- Met
- Late
- Not met
- Today
What the company said
“Complete buildout of Dallas headquarters by mid-year”
What we found
Evidence strength A What the grades mean
The company opened its Dallas headquarters in May 2021, which is before the mid-year 2021 deadline.
-
A Taysha Gene Therapies, Inc. 8-K filed 2021-08-16
“Opened the Dallas headquarters in May 2021” ✓ confirmed on the page
Market reaction: the shares moved -0.7% against the S&P 500 over the three sessions around the disclosure (13 Aug 2021 to 18 Aug 2021). What this measures
Checked 25 Oct 2026.
Commitment DNA
The structured record of this commitment. Fields the company did not state are left blank rather than guessed.
- Event type
- Facility other
- Indicative materiality
- Medium rules
- Action
- Complete
- Deliverable
- Dallas headquarters buildout
- Where
- Dallas
- In the company’s control
- High
- Specificity
- High
How this entry was checked
- Commitment recordedThe company's words were matched word for word against the filing.
- First checkAn AI model, Gemini (Google), read the company's later filings and recorded the outcome with a quoted passage.
- Second check: agreesA different AI model, Claude (Anthropic), re-read the evidence without being told the outcome and reached the same answer.
Confirmed. This outcome counts towards the company's Kept Score. How verification works
Are you Taysha Gene Therapies, Inc.? You can publish an official statement next to this entry, free. Add a statement.
Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.
Report an error in this entry Reference: KI-C-2021-TSHA-022712 · Corrections policy